BeiGene Ltd (ONC)
267.39
+4.79
(+1.82%)
USD |
NASDAQ |
Mar 28, 16:00
267.37
-0.02
(-0.01%)
After-Hours: 20:00
BeiGene Enterprise Value: 27.14B for March 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Gilead Sciences Inc | 154.28B |
| Leap Therapeutics Inc | -34.19M |
| Catalyst Pharmaceuticals Inc | 2.481B |
| Exelixis Inc | 9.160B |
| Halozyme Therapeutics Inc | 8.772B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -151.88M |
| Revenue (Quarterly) | 1.128B |
| Total Expenses (Quarterly) | 1.207B |
| EPS Diluted (Quarterly) | -1.43 |
| Gross Profit Margin (Quarterly) | 85.76% |
| Profit Margin (Quarterly) | -13.47% |
| Earnings Yield | -2.33% |
| Normalized Earnings Yield | -2.334 |